Free Trial
OTCMKTS:OASMY

Vivesto (OASMY) Stock Price, News & Analysis

Vivesto logo
$0.02 0.00 (0.00%)
As of 06/5/2025

About Vivesto Stock (OTCMKTS:OASMY)

Key Stats

Today's Range
$0.02
$0.02
50-Day Range
$0.02
$0.02
52-Week Range
$0.01
$0.05
Volume
N/A
Average Volume
2,050 shs
Market Capitalization
$3.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.

Receive OASMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vivesto and its competitors with MarketBeat's FREE daily newsletter.

OASMY Stock News Headlines

Vivesto AB DRC (OASMY)
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
Vivesto AB ADR OASMY
OMX Stockholm Health Care GI (SX20GI)
See More Headlines

OASMY Stock Analysis - Frequently Asked Questions

Vivesto's stock was trading at $0.04 at the start of the year. Since then, OASMY shares have decreased by 50.0% and is now trading at $0.02.
View the best growth stocks for 2025 here
.

Shares of OASMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
6/06/2025
Next Earnings (Estimated)
8/20/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:OASMY
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$100 thousand
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$3.59 million
Optionable
Not Optionable
Beta
22.72
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (OTCMKTS:OASMY) was last updated on 6/6/2025 by MarketBeat.com Staff
From Our Partners